Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madeleine Duvic

Showing results (1-10 of 407) with videos related to

Pageof 41
Sort By:
Current Hematologic Malignancy Reports|August 19, 2011
CD30+ neoplasms of the skinMadeleine Duvic
Hematology. American Society of Hematology. Education Program|December 6, 2015
Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndromeMadeleine Duvic
Dermatologic Clinics|October 5, 2015
Histone Deacetylase Inhibitors for Cutaneous T-Cell LymphomaMadeleine Duvic
Leukemia & Lymphoma|September 13, 2006
Photopheresis versus transimmunization?Madeleine Duvic
Clinical Lymphoma, Myeloma & Leukemia|September 10, 2010
Rational clinical trial design in cutaneous lymphomaMadeleine Duvic
Oncology (Williston Park, N.Y.)|May 4, 2007
Systemic monotherapy vs combination therapy for CTCL: rationale and future strategiesMadeleine Duvic
American Journal of Clinical Dermatology|August 23, 2008
EGFR inhibitor-associated acneiform folliculitis: assessment and managementMadeleine Duvic
Cancer Treatment Reviews|February 2, 2016
The safety profile of vorinostat (suberoylanilide hydroxamic acid) in hematologic malignancies: A review of clinical studiesMadeleine Duvic, Meletios Dimopoulos
Dermatologic Therapy|December 23, 2003
Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphomaChunlei Zhang, Madeleine Duvic
Journal of the American Academy of Dermatology|July 10, 2004
Cutaneous T-cell lymphomaMadeleine Duvic, Richard Edelson
Pageof 41

Showing results (1-10 of 407) with videos related to

Sort By:
Pageof 41
Current Hematologic Malignancy Reports|August 19, 2011
CD30+ neoplasms of the skinMadeleine Duvic
Hematology. American Society of Hematology. Education Program|December 6, 2015
Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndromeMadeleine Duvic
Dermatologic Clinics|October 5, 2015
Histone Deacetylase Inhibitors for Cutaneous T-Cell LymphomaMadeleine Duvic
Leukemia & Lymphoma|September 13, 2006
Photopheresis versus transimmunization?Madeleine Duvic
Clinical Lymphoma, Myeloma & Leukemia|September 10, 2010
Rational clinical trial design in cutaneous lymphomaMadeleine Duvic
Oncology (Williston Park, N.Y.)|May 4, 2007
Systemic monotherapy vs combination therapy for CTCL: rationale and future strategiesMadeleine Duvic
American Journal of Clinical Dermatology|August 23, 2008
EGFR inhibitor-associated acneiform folliculitis: assessment and managementMadeleine Duvic
Cancer Treatment Reviews|February 2, 2016
The safety profile of vorinostat (suberoylanilide hydroxamic acid) in hematologic malignancies: A review of clinical studiesMadeleine Duvic, Meletios Dimopoulos
Dermatologic Therapy|December 23, 2003
Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphomaChunlei Zhang, Madeleine Duvic
Journal of the American Academy of Dermatology|July 10, 2004
Cutaneous T-cell lymphomaMadeleine Duvic, Richard Edelson
Pageof 41